Product image of Lazulide (Losartan Potassium) supplied by GNH India

Lazulide

Active Ingredient:
Losartan Potassium
Origin:
EU

Lazulide (Losartan Potassium)

Losartan potassium, the active ingredient in Lazulide, is an angiotensin II receptor blocker presented as an oral tablet for oral use. It is used to lower blood pressure and protect the kidneys in patients with hypertension, heart failure, or diabetic nephropathy. It works by blocking the effects of angiotensin II, a hormone that narrows blood vessels, thereby helping to relax vessels and reduce strain on the heart.

GNH India supplies Lazulide as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Ipca Productos Farmaceuticos Unipessoal Lda

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Lazulide (losartan potassium) acts on the renin‑angiotensin‑aldosterone system to manage several cardiovascular and renal conditions.

  • Hypertension: reduces systolic and diastolic blood pressure, lowering risk of cardiovascular events.
  • Heart failure: improves symptoms and reduces hospitalizations by decreasing afterload.
  • Diabetic nephropathy: slows progression of kidney damage by lowering intraglomerular pressure.

How It Works

  • Losartan potassium selectively blocks angiotensin II type 1 (AT1) receptors on vascular smooth‑muscle cells, adrenal cortex, and renal tubular cells. By preventing angiotensin II binding, it inhibits vasoconstriction, aldosterone secretion, and sympathetic activation, leading to vasodilation, reduced sodium‑water retention, and decreased blood‑pressure‑mediated stress on the heart and kidneys. The blockade also diminishes remodeling of cardiac tissue and attenuates proteinuria in the kidney.

Side Effects

Like other ARBs, losartan may cause a range of adverse reactions, from mild to serious.

Common Side Effects

  • Dizziness: light‑headed sensation, especially after standing.
  • Headache: mild to moderate pain in the head.
  • Fatigue: feeling unusually tired or weak.
  • Nasal congestion: blocked or runny nose.
  • Cough: dry irritation of the throat.
  • Back pain: discomfort in the lower spine.

Serious or Rare Side Effects

  • Hyperkalemia: elevated blood potassium that can affect heart rhythm.
  • Acute kidney injury: sudden decline in renal function requiring monitoring.
  • Angio‑edema: rapid swelling of the face, lips, tongue or throat, potentially compromising airway.
  • Liver enzyme elevation: increased transaminases indicating hepatic stress.

Precautions & Warnings

Before prescribing Lazulide, clinicians should evaluate patient history and monitor laboratory parameters.

  • Renal function: assess creatinine and eGFR before initiation and periodically.
  • Electrolytes: monitor serum potassium, especially in patients on potassium‑sparing diuretics.
  • Volume status: avoid use in patients with severe dehydration or volume depletion.
  • Concomitant NSAIDs: use cautiously as they may increase risk of renal impairment.
  • Pregnancy: avoid during the second and third trimesters due to fetal toxicity risk.
  • Store at ambient temperature: keep below 25 °C, protect from moisture and light in the original container.

Avoid Interactions

Losartan can interact with several medicines, altering its efficacy or safety profile.

Major Interactions (Avoid)

  • Potassium supplements or potassium‑sparing diuretics: may cause dangerous hyperkalemia.
  • Aliskiren (in diabetic patients): combined use can increase renal dysfunction and hyperkalemia risk.
  • Dual ARB/ACE inhibitor therapy: heightens risk of hypotension, renal impairment, and hyperkalemia.

Moderate Interactions (Monitor Closely)

  • NSAIDs (ibuprofen, naproxen): can reduce antihypertensive effect and impair renal function.
  • Lithium: may increase lithium levels, risking toxicity.
  • Cyclosporine or tacrolimus: may raise serum creatinine and potassium.

Frequently Asked Questions

Lazulide contains losartan potassium, an angiotensin II receptor blocker indicated for the treatment of hypertension, chronic heart failure, and diabetic nephropathy. It helps lower blood pressure, reduce cardiac workload, and slow kidney damage progression in these patient groups.

Losartan potassium selectively blocks AT1 receptors for angiotensin II, preventing the hormone from causing vasoconstriction and aldosterone release. This results in relaxed blood vessels, reduced sodium and water retention, and lower blood‑pressure‑related stress on the heart and kidneys.

The appropriate dose of Lazulide is determined by the prescribing clinician based on the individual’s medical condition, response to therapy, and renal function. Patients should follow the dosage instructions provided by their healthcare professional.

Losartan potassium is generally contraindicated in the second and third trimesters of pregnancy because it may cause fetal toxicity. Safety during breastfeeding has not been established, so clinicians usually advise against use unless the benefit outweighs potential risks.

To order Lazulide, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

The primary alternative to losartan is the ACE‑inhibitor class (e.g., enalapril). Both lower blood pressure by interfering with the renin‑angiotensin system, but ARBs like losartan are less likely to cause cough and angio‑edema, making them a preferred option for patients who cannot tolerate ACE inhibitors.

Lazulide tablets should be stored at ambient temperature, preferably below 25 °C, in their original packaging to protect from moisture and light. Keep the product out of reach of children and do not use if the packaging is damaged.

Lazulide is taken orally, usually with or without food, as directed by a healthcare professional. The tablet should be swallowed whole with a full glass of water and not crushed or chewed unless specifically instructed.

Serious adverse events include hyperkalemia, acute kidney injury, and angio‑edema. Patients should be alert for symptoms such as rapid swelling of the face or throat, muscle weakness, irregular heartbeat, or a sudden decline in urine output, and seek medical attention promptly.

Lazulide should be avoided in patients with known hypersensitivity to losartan or any component of the formulation, in those with severe renal impairment, and in pregnant women during the second and third trimesters. Caution is also advised for individuals with high potassium levels or those on potassium‑sparing therapies.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Losartan Potassium

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT